V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005128 | 280003354 | 1.7 | 69.5 | Palliative (P) | 2013-03-29 | 2013-04-21 | EW EuroEwing 99 : VIDE | N | N | 280028575 | CISPLATIN + EPIRUBICIN |
| 280005129 | 280003355 | 1.63 | 87.7 | Palliative (P) | 2015-03-31 | 2015-04-07 | GemCarbo Days 1+8 | Y | N | 280028576 | ECX |
| 280005130 | 280003355 | null | 72 | null | null | 2013-02-13 | GemCarbo Days 1+8 | null | null | 280028576 | LU-177 |
| 280005131 | 280003356 | 1.51 | 73 | Palliative (P) | null | 2013-12-29 | Cisplatin + Docetaxel | null | null | 280028582 | PEMBROLIZUMAB |
| 280005132 | 280003357 | null | null | Palliative (P) | 2015-11-25 | 2015-12-06 | Doxorubicin + Olaratumab | 2 | N | 280028583 | CISPLATIN + PEMETREXED |
| 280005133 | 280003358 | 1.61 | 60.75 | Curative (C) | 2015-11-22 | 2015-12-02 | CARBOPLATIN + GEMCITABINE | N | N | 280028584 | CAPECITABINE + OXALIPLATIN |
| 280005134 | 280003358 | 1.73 | null | Palliative (P) | null | 2013-12-15 | Cisplatin + Fluorouracil + RT 5day | null | null | 280028584 | CARBOPLATIN + PEMETREXED |
| 280005135 | 280003359 | 1.65 | 78.6 | Palliative (P) | 2017-05-28 | 2017-05-28 | CARBOPLATIN + FLUOROURACIL | N | N | 280028587 | DACARBAZINE |
| 280005136 | 280003359 | 1.64 | 63.7 | Palliative (P) | 2016-06-12 | 2016-06-20 | Everolimus 10mg | 02 | N | 280028587 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280005137 | 280003359 | 1.76 | null | Palliative (P) | 2014-10-18 | 2014-10-25 | Mitomycin Intravesical | N | N | 280028587 | IRINOTECAN + MDG |
| 280005138 | 280003359 | 1.71 | 83.6 | Disease modification (D) | 2015-11-24 | 2015-12-07 | Cetuximab +Cisplatin + FU (Cycle 1) | 2 | N | 280028587 | LANREOTIDE |
| 280005139 | 280003360 | 1.72 | null | Palliative (P) | 2017-01-16 | 2017-01-17 | Cisplatin + Fluorouracil + RT 5day | Y | N | 280028592 | CAPECITABINE + TEMOZOLOMIDE |
| 280005140 | 280003361 | null | null | 5 | 2013-09-28 | 2013-10-01 | CAPECITABINE + OXALIPLATIN | null | null | 280028593 | CARBOPLATIN + PEMETREXED |
| 280005141 | 280007750 | 1.76 | 39.2 | Palliative (P) | 2015-10-15 | 2015-11-06 | Docetaxel+Gemcitabine (no prior RT) | N | N | 280028594 | OCTREOTIDE |
| 280005142 | 280007750 | 1.75 | 100 | Palliative (P) | 2015-01-01 | 2015-01-02 | FCarboSt | 02 | N | 280028594 | GEMCITABINE |
| 280005143 | 280003362 | 1.62 | 53.3 | Palliative (P) | 2016-03-29 | 2016-04-27 | LANREOTIDE | N | N | 280028597 | CYCLOPHOSPHAMIDE |
| 280005144 | 280003362 | 0 | 54 | Palliative (P) | 2014-05-26 | 2014-05-27 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 280028597 | CAPECITABINE + GEMCITABINE |
| 280005145 | 280003363 | 1.6 | 54.3 | Curative (C) | 2016-04-26 | 2016-04-26 | Cisplatin + Pemetrexed | 02 | N | 280028601 | IPM |
| 280005146 | 280003363 | 1.62 | 57.4 | Palliative (P) | 2014-03-17 | 2014-03-17 | FLUOROURACIL + OXALIPLATIN | N | N | 280028601 | CAPECITABINE + GEMCITABINE |
| 280005147 | 280003364 | 1.64 | 73.2 | Palliative (P) | 2013-06-15 | 2013-06-18 | Hydroxycarbamide | N | N | 280028603 | CAPECITABINE + STREPTOZOCIN |
| 280005148 | 280003364 | 1.79 | 0 | Curative (C) | 2016-04-20 | 2016-04-24 | Capecitabine + Cisplatin | 02 | N | 280028603 | FCR |
| 280005149 | 280003364 | 1.79 | 132.7 | Palliative (P) | 2015-12-17 | 2015-12-17 | Doxorubicin + Olaratumab | Y | Y | 280028603 | OXALIPLATIN + MDG |
| 280005150 | 280003364 | 1.56 | 86 | Palliative (P) | 2015-10-13 | 2015-10-13 | Mitomycin Intravesical | 2 | N | 280028603 | OCTREOTIDE |
| 280005151 | 280003364 | 1.67 | 71.2 | Palliative (P) | 2013-05-01 | 2013-05-03 | TCF | 02 | N | 280028603 | CAPECITABINE |
| 280005152 | 280003365 | 1.65 | 67.1 | Palliative (P) | 2017-09-14 | 2017-10-01 | PACLITAXEL | null | N | 280028610 | CAPECITABINE |
| 280005153 | 280003366 | 1.72 | 72.5 | Palliative (P) | 2009-07-07 | 2014-02-22 | CCEP | N | N | 280028612 | GEMCARBO |
| 280005154 | 280003366 | 1.8 | 85 | Palliative (P) | 2018-07-31 | 2018-08-08 | CARBOPLATIN + CETUXIMAB + FU | 02 | N | 280028612 | ECX |
| 280005155 | 280003366 | 1.82 | 79.6 | Palliative (P) | 2016-12-15 | 2017-01-19 | Carboplatin + Pemetrexed | N | N | 280028612 | ECX |
| 280005156 | 280011047 | null | null | 5 | 2014-11-10 | 2014-11-12 | Docetaxel + Gemcitabine with GCSF | N | null | 280028621 | LANREOTIDE |
| 280005157 | 280003367 | 1.76 | 85 | Palliative (P) | 2017-06-04 | 2017-06-11 | OCTREOTIDE | N | N | 280028622 | OCTREOTIDE |
| 280005158 | 280003368 | 1.7 | null | Palliative (P) | 2014-03-08 | 2014-03-28 | VIDE | N | N | 280028623 | GEMCITABINE |
| 280005159 | 280003368 | null | 54.3 | Palliative (P) | 2014-10-16 | 2014-10-27 | Ifosfamide PVI 1g/m2 14day | N | N | 280028623 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 280005160 | 280003369 | 1.68 | 74.1 | Palliative (P) | 2017-05-01 | 2017-05-02 | FCiSt | 2 | N | 280028627 | CAPECITABINE + GEMCITABINE |
| 280005161 | 280003369 | 1.76 | 101.3 | null | 2016-06-10 | 2016-06-15 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280028627 | GEMCARBO |
| 280005162 | 280003369 | 1.78 | 73.9 | Palliative (P) | 2017-10-11 | 2017-10-15 | VIDE | 2 | N | 280028627 | CAPECITABINE |
| 280005163 | 280011048 | null | 86.8 | Palliative (P) | 2012-12-30 | 2014-01-20 | VIDE | N | N | 280028630 | GEMCITABINE |
| 280005164 | 280003370 | 1.67 | 85.6 | Palliative (P) | 2013-10-29 | 2013-10-30 | Gemcitabine weekly | 02 | N | 280028632 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280005165 | 280003370 | null | null | Palliative (P) | 2013-09-19 | 2013-09-23 | Cisplatin + Doxorubicin | N | N | 280028632 | CAPECITABINE + OXALIPLATIN |
| 280005166 | 280003370 | 1.86 | null | Adjuvant (A) | 2014-11-08 | 2014-11-08 | Cisplatin + Doxorubicin | Y | N | 280028632 | VINORELBINE |
| 280005167 | 280003370 | 1.77 | 72.2 | Palliative (P) | 2014-11-20 | 2017-02-04 | VIDE | N | N | 280028632 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 280005168 | 280003371 | 1.78 | 68 | Disease modification (D) | 2014-05-07 | 2014-05-07 | CARBO + FLUOROURACIL | 01 | N | 280028640 | CAPECITABINE |
| 280005169 | 280003371 | null | 56.9 | Adjuvant (A) | 2015-07-08 | 2015-08-02 | Sorafenib | null | N | 280028640 | BENDAMUSTINE |
| 280005170 | 280003372 | 1.87 | 69.4 | Palliative (P) | 2015-02-13 | 2015-02-16 | CompARE Trial | 2 | N | 280028643 | OXALIPLATIN + MDG |
| 280005171 | 280003372 | 1.57 | null | Palliative (P) | 2016-01-15 | 2016-01-16 | VIDE | 02 | N | 280028643 | OXALIPLATIN + MDG |
| 280005172 | 280003372 | 1.66 | 77 | Palliative (P) | 2017-10-20 | 2017-10-27 | ECX | N | N | 280028643 | ECX |
| 280005173 | 280003372 | 1.63 | 70.6 | Palliative (P) | 2016-10-04 | 2016-10-17 | Cisplatin + Fluorouracil + RT 5day | N | N | 280028643 | INTERFERON |
| 280005174 | 280003372 | 1.58 | 28.25 | Palliative (P) | 2017-02-23 | 2017-02-23 | Cisplatin + Fluorouracil + RT 5day | N | null | 280028643 | ECX |
| 280005175 | 280003372 | 1.53 | 109.9 | Palliative (P) | 2014-05-22 | 2014-05-26 | LANREOTIDE | N | N | 280028643 | ECX |
| 280005176 | 280003373 | 1.7 | 0 | Palliative (P) | null | 2013-12-25 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280028653 | ECARBOX |
| 280005177 | 280003374 | 1.77 | 79.8 | Palliative (P) | null | 2016-07-24 | Pazopanib | N | N | 280028655 | BLEOMYCIN + CISPLATIN + VINCRISTINE |